Tag: Regulatory Updates

Medical Devices – Europe, Asia and ROW Regulatory News – Feb. 2024

March 5, 2024
Medical Device

EUROPE Expression of interest open – Possible second call for EU reference laboratories for high-risk in vitro diagnostic medical devices The Commission, after consulting the Member States in...

Compliance, Global Health, Health Policy, Healthcare Industry, Medical Devices, Medical Technology, Regulations, Regulatory Updates

Consumer Health USA/Asia/ROW Regulatory News – Jan 2024

February 8, 2024
Consumer Health

USA FDA announces availability of Additional Submission Tools for Cosmetic Facility Registration and Product Listing The U.S. Food and Drug Administration (FDA) officially launched additional...

Asia Regulations, Consumer Health, FDA, Regulatory Updates, ROW Imports

Recap 2023 : Key Medical Device Regulatory highlights in Asia and ROW

January 31, 2024
Medical Device

ASIA CHINA Notice from the Device Review Center of the State Food and Drug Administration on the release of key points for the functional review of artificial intelligence software for magnetic...

Healthcare Compliance, Medical Devices, Regulatory Updates

Pharma/Biotech – Asia, ROW Regulatory News, Nov. 2023 Vol. 2

November 29, 2023
Biopharma

ASIA Malaysia Guideline for Facilitated Registration Pathway (FRP) NPRA revised Guideline for Facilitated Registration Pathway (FRP). The revised pathway includes registration schemes that...

Asia Regulatory News, BioTech, Conditional Approval, Facilitated Registration Pathway, Pharma, Regulatory Updates, ROW Regulatory News, Therapeutic Goods

Swissmedic Device/IVD Database Key Dates

November 3, 2023
Medical Device

Swissmedic now handles registration of economic operators, medical devices and in vitro diagnostic medical devices directly, since the agreement on mutual recognition of conformity assessments...

IVD Regulations, Medical Device Compliance, Medical Device Manufacturers, Regulatory Updates, Swissmedic

Pharma/Biotech – Asia, ROW Regulatory News, Oct. 2023 Vol. 2

October 26, 2023
Biopharma

ASIA Pakistan DRAP outlines pharma implications of Pakistan’s hazardous waste policy The Drug Regulatory Authority of Pakistan (DRAP) has shared information about how national guidelines on...

Asia Regulatory News, BioTech, Pharma, Regulatory Updates, ROW Regulatory News